Search
Enter keywords, a title or a report id number below.
Your Search for 'Pharmaceuticals - Netherlands - a snapshot (2011)' returned 50 results - Page 1 of 3
Sort by
Sorted by
Rank
Top-Bottom
-
Thermic Fluid Market by Product (Silicone and Aromatics, Mineral Oils, Glycol Based Fluids, etc.), by Application (Oil and Gas, Chemicals, Solar, Pharmaceuticals, etc.) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Transparency Market Research, May 2013 , Pages: 92fluids, also known as heat transfer fluids (HTF) in terms of revenue and volumes from 2011 to 2018. The study provides a comprehensive snapshot of the thermic fluids industry by segmenting the market into ... -
Netherlands Pharmaceuticals and Healthcare Report Q4 2011
Business Monitor International, Aug 2011 , Pages: 78Netherlands Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's Netherlands Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ... -
Spasticity - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 79team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario ... -
Netherlands Pharmaceuticals and Healthcare Report Q2 2012
Business Monitor International, Feb 2012 , Pages: 80: While the Netherlands is a low risk market from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe countries ... -
Netherlands Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Nov 2010 , Pages: 77Netherlands Pharmaceuticals and Healthcare Report Q1 2011 Netherlands Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ... -
RNA Interference (RNAi) - Global Strategic Business Report
Global Industry Analysts, Inc, Apr 2012 , Pages: 792Pharmaceuticals, Inc., Benitec Limited, Bioneer Corp., Calando Pharmaceuticals, Inc., Cenix BioScience GmbH, Devgen NV, Dharmacon, Inc., Dicerna Pharmaceuticals, Inc., Exiqon A/S, Genesis Research & Development ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ... -
Netherlands Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 81, especially during the patent cliff years. Headline Expenditure Projections - Pharmaceuticals: EUR5.90bn (US$7.83bn) in 2010 to EUR5.94bn (US$8.50bn) in 2011; +0.7% growth in local currency terms and +8.6 ... -
Netherlands Pharmaceuticals and Healthcare Report Q2 2010
Business Monitor International, Feb 2010 , Pages: 78sales will reach EUR6.11bn (US$8.85bn), before declining to EUR6.08bn (US$8.57bn) as medicines start to lose intellectual property protection in 2011. By 2014, pharmaceutical expenditure in the Netherlands ... -
Daiichi Sankyo Company, Ltd - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011 , Pages: 338Biota For Development Of New Influenza Antiviral Sep 28, 2011: Valeant Pharmaceuticals Receives Approval For Colesevelam Hydrochloride In Canada Jul 19, 2011: Daiichi Sankyo Launches LIXIANA In ... -
Colon Cancers - Pipeline Review, Q1 2011
Global Markets Direct, Feb 2011 , Pages: 152., 2011 Oncothyreon Inc, 2011 OncoVista Innovative Therapies, Inc., 2011 Compugen Ltd., 2011 Patrys Limited, 2011 Cosmo Pharmaceuticals S.p.A, 2011 Critical Outcome Technologies Inc., 2011 ... -
Harbor BioSciences, Inc. - Product Pipeline Review - Q1 2011
Global Markets Direct, May 2011 , Pages: 54Harbor BioSciences, Inc. - Product Pipeline Review - Q1 2011 Harbor BioSciences, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Harbor BioSciences ... -
Animal Feed Additives - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2012 , Pages: 762, Mexico, Japan, and Rest of World (includes corresponding Graph/Chart) II-16 Table 19: Worldwide Compound Feed Production by Region/Country (2011): Percentage Breakdown of Volumes for Europe, US ... -
Hungary Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 100achieved. Headline Expenditure Projections: - Pharmaceuticals: HUF678bn (US$3.27bn) in 2010 to HUF696bn (US$3.74bn) in 2011; +2.6% in local currency terms and +14.3% in US dollar terms. Forecast ... -
Healthcare Plastics - A Global Market Watch, 2011 - 2016
Axis Research Mind, Dec 2012- EFFECTS OF GLOBAL RECESSION PLASTICS IN MEXICO THE AMERICAS MARKET SNAPSHOT EUROPE THE ASSOCIATION OF ITALIAN PLASTICS AND RUBBER RECORDS A GROWTH IN 2011 EUROPEAN COMMISSION'S REGULATION 450/2009 ON ... -
Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015
Axis Research Mind, Nov 2011 , Pages: 730billion, respectively by 2015. Pharmaceuticals account for the largest share of the entire market, driving a CAGR of 8.5% during the analysis period 2009-2015. Biotechnology sees as the fastest growing ... -
Biorepositories: Ownership & End-Users - A Global Market Watch, 2009-2015
Axis Research Mind, Nov 2011 , Pages: 730respectively. Pharmaceuticals account for the largest share of the entire market, driving a CAGR of 8.5% during the analysis period 2009-2015. Biotechnology sees as the fastest growing end-user with a forecast ... -
Biorepositories: Technologies & End-Users - A Global Market Watch, 2009-2015
Axis Research Mind, Nov 2011 , Pages: 629expected to attain US$2.4 billion market value by 2015 with a CAGR of 8.3%. Pharmaceuticals account for the largest share of the entire market, driving a CAGR of 8.5% during the analysis period 2009-2015 ... -
Galapagos NV - Product Pipeline Review - Q2 2011
Global Markets Direct, Jul 2011 , Pages: 91Galapagos NV - Product Pipeline Review - Q2 2011 Galapagos NV – Product Pipeline Review – Q2 2011 Summary Global Market Direct’s pharmaceuticals report, “Galapagos NV - Product Pipeline Review - Q2 ... -
Blood Banking And Blood Products - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2012 , Pages: 1025count from more than twenty to five. In 2011, Grifols took over Talecris, and players holding the majority share reduced to four. The US leads in the provision of sourced plasma and is also the biggest ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
